Finnish prostate cancer study reveals treatment patterns and outcomes
NCT ID NCT05701007
First seen Jan 31, 2026 · Last updated May 22, 2026 · Updated 14 times
Summary
This study looked at over 1,000 men in Finland with metastatic prostate cancer to understand their health, treatments, and how the disease progresses. Researchers collected information from medical records to see what treatments were used and how well they worked. The goal was to fill gaps in knowledge about the disease's impact in Finland.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC CASTRATION SENSITIVE PROSTATE CANCER (MCSPC) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Pfizer
Helsinki, Finland
Conditions
Explore the condition pages connected to this study.